Testing effectiveness (Phase 2)Ended earlyNCT03800420What this trial is testingEfficacy and Safety of BBT-401-1S in Ulcerative ColitisWho this might be right forUlcerative Colitis Bridge Biotherapeutics, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01100112What this trial is testing(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release TabletsWho this might be right forColitis, Ulcerative Bausch Health Americas, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01482884What this trial is testingEvaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisWho this might be right forUlcerative Colitis AstraZeneca 147
Early research (Phase 1)Study completedNCT02818543What this trial is testingSafety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative ColitisWho this might be right forUlcerative Colitis Lycera Corp. 6
Not applicableStudy completedNCT02622139What this trial is testingMultispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)Who this might be right forCrohn's DiseaseUlcerative ColitisIBD University of Erlangen-Nürnberg Medical School 344
Testing effectiveness (Phase 2)Study completedNCT00808977What this trial is testingA Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative ColitisWho this might be right forUlcerative Colitis Palau Pharma S.L.U. 80
Testing effectiveness (Phase 2)Study completedNCT00063414What this trial is testingISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative ColitisWho this might be right forUlcerative Colitis Ionis Pharmaceuticals, Inc.
Not applicableActive Not RecruitingNCT05496348What this trial is testingStudy of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative ColitisWho this might be right forUlcerative Colitis AbbVie 400
Post-approval studies (Phase 4)Ended earlyNCT00947674What this trial is testingLeukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Asahi Kasei Medical Co., Ltd. 52
Early research (Phase 1)UnknownNCT05743010What this trial is testingA Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative ColitisWho this might be right forUlcerative Colitis Jiangsu Yahong Meditech Co., Ltd aka Asieris 36
Testing effectiveness (Phase 2)WithdrawnNCT04096573What this trial is testingEfficacy and Safety of LC51-0255 in Subjects With Ulcerative ColitisWho this might be right forUlcerative Colitis LG Chem
Testing effectiveness (Phase 2)Ended earlyNCT03977480What this trial is testingPhase II Study of Hemay007 in Patients With Active Ulcerative ColitisWho this might be right forUlcerative Colitis Tianjin Hemay Pharmaceutical Co., Ltd 70
Early research (Phase 1)Study completedNCT01290042What this trial is testingStudy to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.Who this might be right forUlcerative ColitisCrohn's Disease Amgen 43
Testing effectiveness (Phase 2)Study completedNCT00659802What this trial is testingPhase II Study of HMPL-004 in Patients With Ulcerative ColitisWho this might be right forUlcerative Colitis Hutchison Medipharma Limited 224
Testing effectiveness (Phase 2)Study completedNCT04102852What this trial is testingLactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC PatientsWho this might be right forUlcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate San Giovanni Addolorata Hospital 76
Testing effectiveness (Phase 2)Looking for participantsNCT06764615What this trial is testingA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)Who this might be right forCrohn's DiseaseUlcerative Colitis Takeda 192
Large-scale testing (Phase 3)Active Not RecruitingNCT06052059What this trial is testingEvaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)Who this might be right forUlcerative Colitis Merck Sharp & Dohme LLC 1,020
Large-scale testing (Phase 3)Ended earlyNCT01349673What this trial is testingThe Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or ProctosigmoiditisWho this might be right forProctitisProctosigmoiditis Bausch Health Americas, Inc. 114
Large-scale testing (Phase 3)Study completedNCT01745770What this trial is testingTID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)Who this might be right forActive Ulcerative Colitis Dr. Falk Pharma GmbH 306
Testing effectiveness (Phase 2)Study completedNCT03648541What this trial is testingBI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative ColitisWho this might be right forColitis, Ulcerative Boehringer Ingelheim 79